Glucagon is the primary hormone that stimulates the breakdown of polymerized glucose, which your body stores as glycogen. When blood glucose drops, the pancreas releases glucagon, which triggers liver cells to dismantle their glycogen reserves and release glucose back into the bloodstream. Epinephrine (adrenaline) and norepinephrine also stimulate this process, particularly during exercise and stress.
Glucagon: The Primary Signal
Glycogen is simply a large, branched chain of glucose molecules linked together, stored mainly in your liver and skeletal muscles. When blood sugar falls, alpha cells in the pancreas detect the change and release glucagon. In a fasting state, with blood glucose hovering around 5 mmol/L (90 mg/dL), glucagon is secreted at baseline levels. As glucose drops further into hypoglycemic territory, glucagon secretion ramps up significantly. Low blood sugar is the single most potent trigger for glucagon release.
Once released, glucagon travels through the bloodstream and binds to receptors on liver cells. This binding sets off an internal signaling cascade that ultimately breaks glycogen apart, one glucose unit at a time. The process is called glycogenolysis.
How the Signaling Cascade Works
When glucagon locks onto its receptor on a liver cell, it activates an enzyme called adenylyl cyclase. This enzyme produces a small signaling molecule, cyclic AMP (cAMP), inside the cell. Rising cAMP levels activate a protein called protein kinase A (PKA) by causing its regulatory subunits to release its active catalytic subunits.
PKA then phosphorylates (chemically switches on) an enzyme called phosphorylase kinase, which in turn activates glycogen phosphorylase. Glycogen phosphorylase is the enzyme that does the actual work: it clips individual glucose units off the glycogen chain, producing glucose-1-phosphate. A second enzyme called debranching enzyme handles the branch points in the glycogen molecule, allowing full degradation of the polymer. The glucose-1-phosphate is then converted to regular glucose and released into the blood.
At the same time, PKA phosphorylates glycogen synthase, the enzyme responsible for building glycogen. This switches it off. So the cascade accomplishes two things simultaneously: it accelerates glycogen breakdown and halts glycogen construction.
Epinephrine and Norepinephrine
Glucagon isn’t the only hormone that triggers glycogenolysis. Epinephrine and norepinephrine, released from the adrenal glands during stress, exercise, or a fight-or-flight response, use a very similar cAMP-dependent signaling pathway to break down glycogen. Norepinephrine in particular helps maintain blood sugar stability during hypoglycemia through this mechanism.
The key difference is where these hormones act most strongly. Epinephrine is especially important in skeletal muscle, where it drives rapid glycogen breakdown to fuel intense physical activity. Glucagon, by contrast, acts primarily on the liver.
Liver vs. Muscle: Two Different Purposes
Your body stores about three-quarters of its total glycogen in skeletal muscles, with most of the remainder in the liver. These two stores serve fundamentally different purposes.
Liver glycogen exists to maintain blood sugar for the entire body. When glucagon triggers glycogenolysis in the liver, the resulting glucose is exported into the bloodstream, where it can reach the brain, red blood cells, and other tissues that depend on a steady glucose supply. This is why glucagon’s primary target is the liver.
Muscle glycogen, on the other hand, is fuel reserved for local use. When your muscles break down their glycogen stores during exercise, the glucose stays inside the muscle cell and is burned for energy on the spot. Muscles lack the enzyme needed to release free glucose into the bloodstream. If muscles had to rely solely on blood glucose for intense activity, your body would run out of circulating sugar almost immediately.
At the start of exercise, both systems kick in. Your liver begins breaking down glycogen to keep blood glucose stable, while your working muscles tap their own internal reserves for the energy they need.
How Insulin Opposes the Process
Insulin, released by the pancreas when blood sugar is high, acts as the counterbalance to glucagon. Rather than activating glycogen breakdown, insulin promotes glycogen storage and actively shuts down glycogenolysis.
One of insulin’s key mechanisms in the liver involves deactivating glycogen phosphorylase, the same enzyme that glucagon’s cascade switches on. Insulin stimulates a phosphatase (an enzyme that removes phosphate groups), which converts the active form of glycogen phosphorylase back to its inactive form. This has a cascading effect of its own: once active phosphorylase is cleared away, it stops blocking the activation of glycogen synthase, the enzyme that builds glycogen. So insulin simultaneously halts breakdown and restarts construction.
This tug-of-war between glucagon and insulin is how your body keeps blood sugar within a narrow, healthy range at all times. After a meal, insulin dominates and glucose gets packed into glycogen. Between meals and overnight, glucagon takes over and glycogen gets broken back down into glucose.
Cortisol’s Supporting Role
Cortisol, often called the stress hormone, is sometimes listed alongside glucagon and epinephrine as a glycogenolytic hormone. Its actual role is more nuanced. Research on liver cells shows that glucagon can trigger glycogen breakdown perfectly well without cortisol present. Cells grown without cortisol still responded to glucagon and still produced the cAMP signal needed to activate the breakdown pathway.
Cortisol’s contribution to blood sugar management works through different mechanisms, primarily by promoting the creation of new glucose from non-sugar sources and by reducing glucose uptake in certain tissues. It supports the overall counter-regulatory response to low blood sugar, but it is not a direct trigger of glycogenolysis the way glucagon and epinephrine are.